After discovering that a drug research firm had tampered with records and manipulated test data, the FDA was expected to move swiftly to compel new testing and to publicly warn patients and doctors. Instead, the agency decided to handle the matter quietly, evaluating the medicines with virtually no public disclosure of what it had discovered. It pulled none of the drugs from the market, even temporarily, letting consumers take the ibuprofen and other medicines it no longer knew for sure were safe and effective. Read more»
to our supporters
- Holly Finstrom
- Michael Toburen
- Luise Levy
- Vote Regina Romero
- The Alben F. Bates and Clara G. Bates Foundation
- Stephen Golden & Susan Tarrence
- Lincoln Steffens
- The Water Desk
- Rocco's Little Chicago
- John S. and James L. Knight Foundation
- Ethics and Excellence in Journalism Foundation
- & many more!
We rely on readers like you. Join them & contribute to the Sentinel today!
A number of drug companies have been accused of illegally promoting powerful antipsychotics off-label to doctors and pharmacies, including those that serve nursing home residents. Read more»